This study revealed that co-activation of both GR and PPARγ using dexamethasone and the PPARγ-ligand rosiglitazone was more efficient in suppressing AD skin inflammation than single nuclear receptor activation (65). This evidence concerns the gene PPARG and Alzheimer disease.